U.S. Transportation Stock News

NYSE:WMS
NYSE:WMSBuilding

Are Zacks Downgrades and Earnings Cuts Reframing Advanced Drainage Systems’ (WMS) Capital Allocation Story?

Earlier this week, Advanced Drainage Systems, Inc. was added to the Zacks Rank #5 (Strong Sell) list after its current-year earnings estimates were revised downward by 4.5% over the past 60 days, reflecting a weaker near-term earnings outlook. This downgrade comes on top of slowing revenue growth, declining earnings per share over the last two years, and a reduced return on invested capital, pointing to fewer high-return growth opportunities for the business. Next, we'll examine how the...
NYSE:CCL
NYSE:CCLHospitality

Carnival (CCL) Stock Faces Softer Q2 EPS As Bullish Margin Narrative Gets Tested

Carnival (CCL) opened Q2 2026 with revenue of US$6.7b and basic EPS of US$0.39, setting a clear marker for its latest earnings season update. The company reported quarterly revenue of US$6.3b in Q2 2025 and US$6.7b in Q2 2026, while basic EPS moved from US$0.43 to US$0.39 over the same period. Over the last twelve months, trailing basic EPS reached US$2.28 on revenue of US$27.3b. For investors, the combination of higher revenue over time and sustained profitability indicates that margins are...
NasdaqCM:AXGN
NasdaqCM:AXGNMedical Equipment

Axogen (AXGN) Stock After 314% One-Year Surge Is The Rally Losing Steam?

Investors may be wondering whether Axogen at US$42.52 still makes sense after such a strong run, or if the current price is getting ahead of itself. The stock has pulled back about 4.6% over the past week, after rising 4.0% over 30 days, 37.2% year to date, 314.8% over 1 year and 373.5% over 3 years, with a 96.8% return across 5 years. Recent coverage has focused on Axogen's share price performance and how the stock's sharp moves compare with broader medical equipment peers. This has put...
NasdaqGS:TYRA
NasdaqGS:TYRABiotechs

Tyra Biosciences (TYRA) Gains Attention On Phase II Results, Is The Upside Already Priced In?

Recent Phase II results for Dabogratinib, Tyra Biosciences (TYRA) experimental therapy for non-muscle invasive bladder cancer, have drawn fresh attention to the company, its late stage pipeline, and how the stock reflects that potential. See our latest analysis for Tyra Biosciences. Tyra Biosciences share price has been volatile around the latest Dabogratinib update, with a 1-day share price return of 1.03% and 7-day share price return of 4.47%, set against a 30-day share price return that is...
NasdaqGS:DAKT
NasdaqGS:DAKTElectronic

Daktronics (DAKT) Is Down 6.8% After Returning To Profit And Expanding Buyback Program

Daktronics, Inc. recently reported fourth-quarter 2026 sales of US$208.61 million and net income of US$8.42 million, alongside full-year sales of US$838.71 million and net income of US$45.38 million, marking a shift from losses a year earlier. At the same time, Daktronics increased its equity buyback authorization to US$40 million, underlining management’s confidence in the company’s financial position and cash-generation profile. We’ll now look at how Daktronics’ move from loss to profit...
NYSE:MGM
NYSE:MGMHospitality

Did MGM’s Renewed Exclusive MLB Partnership Just Shift MGM Resorts International's (MGM) Investment Narrative?

MGM Resorts International and BetMGM recently renewed their multi‑year partnerships with Major League Baseball, keeping MGM as MLB’s exclusive Integrated Resort & Casino Partner and extending BetMGM’s marketing presence across MLB media, events, and co‑branded gaming products in the U.S. and Canada. This renewal strengthens MGM’s access to baseball fans through awards events in Las Vegas, team partnerships, and MLB‑themed betting and casino experiences, potentially deepening the link between...
NYSE:BLD
NYSE:BLDConsumer Durables

TopBuild (BLD) Moves Ahead With QXO Merger As Lawsuit And Debt Changes Loom

TopBuild (NYSE:BLD) is moving ahead with its proposed merger with QXO as stockholders pursue a legal challenge focused on the company’s proxy disclosures. The merger process is taking place alongside major recent amendments to TopBuild’s senior debt terms that are tied to financing the acquisition. These developments affect TopBuild’s governance and capital structure and add new information to the merger story beyond earlier valuation focused discussion. TopBuild, a large installer and...
NasdaqCM:ATEX
NasdaqCM:ATEXTelecom

Anterix (ATEX) Stock After Strong 2024 Rally Is The Current Price Justified

If you are wondering whether Anterix stock is still reasonably priced after its strong run, the next sections will walk through what the current valuation might be telling you. The stock last closed at US$79.09, with returns of 6.1% over the past week, 24.1% over the past month, 255.8% year to date, and 200.3% over the past year. This performance has put Anterix firmly on many investors' radar as they reassess potential reward and risk. Recent news around Anterix has focused on its position...
NYSE:FN
NYSE:FNElectronic

High Growth Tech Stocks To Watch In US June 2026

Over the last 7 days, the United States market has dropped 2.5%, yet it remains up by 20% over the past year, with earnings forecasted to grow annually by 19%. In this dynamic environment, identifying high growth tech stocks involves evaluating their potential to capitalize on technological advancements and market trends while navigating recent fluctuations.
NYSE:AHR
NYSE:AHRHealth Care REITs

3 Promising Stocks Trading 25.2% to 33.7% Below Intrinsic Value Estimates

Over the last 7 days, the United States market has dropped 2.5%, yet it has risen by 20% over the past year with earnings forecasted to grow by 19% annually. In this context of fluctuating short-term performance and promising long-term growth potential, identifying stocks that are trading significantly below their intrinsic value estimates can offer attractive opportunities for investors seeking value in a robust market environment.
NasdaqGM:BWMN
NasdaqGM:BWMNConstruction

Spotlight On Bowman Consulting Group And 2 Other Insider-Owned Growth Leaders

In the United States market, recent fluctuations have seen a 2.5% drop over the last week, yet it still boasts a 20% increase over the past year with anticipated earnings growth of 19% annually in the coming years. In such an environment, stocks with strong insider ownership can be particularly appealing as they often signal confidence from those closest to the company's operations and long-term potential.
NasdaqGS:MQ
NasdaqGS:MQDiversified Financial

Spotlight On 3 Penny Stocks With Market Caps Under $2B

Over the last 7 days, the market has dropped 2.5%, but over the past year, it is up 20% with earnings forecasted to grow by 19% annually. For investors willing to explore beyond well-known names, penny stocks—often representing smaller or newer companies—can offer intriguing opportunities. Despite being a somewhat outdated term, these stocks remain relevant for their potential to uncover hidden value in companies with solid financial foundations.